Arrowstreet Capital Limited Partnership Grows Stake in Bath & Body Works, Inc. $BBWI

Arrowstreet Capital Limited Partnership raised its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 34.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,777,576 shares of the company’s stock after buying an additional 707,449 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Bath & Body Works were worth $51,857,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. Parallel Advisors LLC lifted its stake in Bath & Body Works by 42.6% in the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after acquiring an additional 567 shares during the period. State of Michigan Retirement System increased its position in Bath & Body Works by 1.2% during the 1st quarter. State of Michigan Retirement System now owns 49,300 shares of the company’s stock valued at $920,000 after purchasing an additional 600 shares during the period. Meeder Asset Management Inc. increased its position in Bath & Body Works by 28.5% during the 4th quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock valued at $58,000 after purchasing an additional 637 shares during the period. State of Wyoming raised its holdings in Bath & Body Works by 6.2% in the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after purchasing an additional 661 shares in the last quarter. Finally, Vident Advisory LLC raised its holdings in Bath & Body Works by 2.8% in the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after purchasing an additional 692 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on BBWI shares. Barclays dropped their target price on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research report on Thursday, May 28th. TD Cowen increased their price target on shares of Bath & Body Works from $20.00 to $25.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Piper Sandler started coverage on shares of Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price objective for the company. Telsey Advisory Group lowered their price objective on shares of Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a report on Thursday, May 28th. Finally, UBS Group reduced their target price on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, May 20th. Three research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $22.00.

Bath & Body Works Trading Up 2.8%

Shares of Bath & Body Works stock opened at $20.47 on Tuesday. The firm has a market capitalization of $4.13 billion, a P/E ratio of 5.75, a P/E/G ratio of 1.97 and a beta of 1.38. The business has a fifty day simple moving average of $19.90 and a two-hundred day simple moving average of $20.43. Bath & Body Works, Inc. has a 12 month low of $14.27 and a 12 month high of $32.32.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The firm had revenue of $1.38 billion for the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The company’s quarterly revenue was down 3.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.49 EPS. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Analysts predict that Bath & Body Works, Inc. will post 2.63 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Investors of record on Friday, June 5th were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, June 5th. This represents a $0.80 annualized dividend and a yield of 3.9%. Bath & Body Works’s payout ratio is presently 22.47%.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.